Reuters logo
BRIEF-Active Biotech Q2 loss narrows, Anyara project activities on hold
August 7, 2014 / 6:41 AM / 3 years ago

BRIEF-Active Biotech Q2 loss narrows, Anyara project activities on hold

Aug 7 (Reuters) - Active Biotech : * Says net sales 2.7 million crowns April-June (2.5 mln Q2 2013) * Q2 - operating loss -57.9 million sek (versus -79.5 Q2 2013) * Says will not commence the further clinical development of Anyara on an

independent basis and will only proceed together with a partner * Says all Anyara project activities will be put on hold until further notice * Says development program for further clinical development of Anyara outlined

in collaboration with regulatory authorities Link to full report: here

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below